James Sabry at #JPM24 (Brian Benton Photography)

Af­ter 14 years call­ing part­ner­ing shots at Genen­tech/Roche, James Sabry is head­ed back in­to the biotech fray

James Sabry, the long­time doyen of biotech deal­mak­ers from his glob­al perch at Roche/Genen­tech, is jump­ing to the US biotech scene.

The Basel-based phar­ma gi­ant …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.